Localization of 3H-imipramine binding sites in the cerebral cortex of rats was studied on the 19th day of prenatal development and on the 3d and 14th days of postnatal ontogenesis. Imipramine was injected into rats on days 17, 18 and 19 of gestation. The maximal imipramine receptor density was found in cortex layers IV-V. The therapeutic doses of imipramine provoked marked stimulation of the formation of imipramine receptors on the 3d day of postnatal development. However, on the 14th day the 3H-imipramine binding level was stabilized.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Platelet serotonergic parameters and clinical symptoms of psychosis in patients with episodic progressive schizophrenia].
Zh Nevrol Psikhiatr Im S S Korsakova
August 2008
A sample included 59 patients, 38 males and 21 females, mean age (M+/-SD) 33,4+/-10,2 years, age-at-onset 26+/-9,5 years, illness duration 7,8+/-6,1 years, with episodic progressive schizophrenia (ICD-10: schizophrenia, paranoid type, F20.0) with continuous course at the stage of exacerbation. Clinical symptoms were assessed using the PANSS.
View Article and Find Full Text PDFEffects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells.
Metab Brain Dis
June 2004
Division of Pharmacology, Potchefstroom Campus of the North-West University, Potchefstroom, South Africa.
myo-Inositol (mI) is a key metabolic precursor to the phospoinositide (PI) metabolic pathway as a key component of central G-protein coupled receptor signaling systems, including several subtypes of adrenergic, cholinergic, serotonergic and metabotropic glutamatergic receptors. High dose mI has also been shown to be clinically effective in the treatment of obsessive-compulsive disorder, as well as panic and depression, although its mechanism of action remains elusive. The current study aimed to investigate the possible modulatory role of mI versus fluoxetine or imipramine pretreatments on serotonin-2A receptor (5HT2A-R) and muscarinic acetylcholine receptor (mAChR) function and binding in in vitro systems.
View Article and Find Full Text PDF[The nature of the interactions of imipramine and serotonin with human lymphocytes].
Eksp Klin Farmakol
March 1998
Department of Biochemistry, Sechenov Moscow Medical Academy, Moscow, Russia.
The work deals with the study of tritium-labeled serotonin (3H-5-hydroxytryptamine, 3H-5-HT) binding with mononuclear leukocytes (lymphocytes) isolated from human peripheral blood. It was shown that 3H-5-HT interacts specifically with the lymphocytes according to the type of reversible, saturated, and temperature-dependent receptor binding. The parameters of binding of the dissociation constant of the ligand-receptor complex and the maximum concentration of the binding centers were determined.
View Article and Find Full Text PDFSeasonal patterns in platelet ligand binding are related to membrane proteins.
Biol Psychiatry
March 1996
Veterans Administration Medical Center, Long Beach, CA, USA.
A seasonal pattern of platelet [3H]imipramine (3H-IMI) binding was explained by a similar but inverted pattern in membrane protein levels in repeated measures of 20 normal volunteers. No seasonal pattern was evident when 3H-IMI binding was expressed on the basis of surface area rather than membrane protein. Platelet Bmax levels in 50 depressed patients were lower than those of controls when values were expressed in terms of platelet surface area.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!